The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reversal of glucocorticoid resistance by the g-secretase inhibitor PF-03084014 in T-cell acute lymphoblastic leukemia.
J. B. Samon
No relevant relationships to disclose
M. Castillo-Martin
No relevant relationships to disclose
J. L. Jakubczak
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
S. Randolph
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
C. Cordon-Cardo
No relevant relationships to disclose
A. A. Ferrando
Research Funding - Pfizer